Håkan Jarbin

High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study

PURPOSE: This study aims to assess the risk of metabolic side effects among paediatric new users of antipsychotics in Sweden, focusing on differences between substances and sexes. METHODS: Children aged 5-17 years, who were new users of antipsychotics between 2014 and 2021, were...